178 - Diagnostic Clinical Cases: What Do I Do With This Test Result?

Friday, October 18, 2024

3:15 PM – 4:30 PM US PT

Location: Petree D

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Interactive Moderator(s)

Esther Babady, PhD (she/her/hers)

Chief, Clinical Microbiology Service
Laboratory Medicine
Memorial Sloan Kettering
New York, NY, United States

Slides
Thea Brennan-Krohn, MD, D(ABMM) (she/her/hers)

Assistant Professor of Pediatrics and Pathology
Harvard Medical School
Boston, MA, United States

Moderator(s)

Nira Pollock, MD, PhD (she/her/hers)

Co-Director, Infectious Diseases Diagnostic Lab/Associate Professor of Pathology and Medicine, HMS
Boston Children's Hospital
Boston, MA, United States

Panelist(s)

David Gaston, MD PhD

Assistant Professor, Medical Director (Molecular Infectious Disease Laboratory)
Vanderbilt University Medical Center
Nashville, TN, United States
Christopher Polage, MD, MAS (he/him/his)

Adjunct Associate Professor, Department of Pathology
Duke University School of Medicine
Chapel Hill, NC, United States
Stanley Deresinski, MD

Clinical Professor of Medicine
Stanford University
Monica Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP (she/her/hers)

Clinical Pharmacy Specialist, Ambulatory/Infectious Diseases
Beth Israel Deaconess Medical Center
Boston, MA, United States
Virginia Pierce, MD (she/her/hers)

Clinical Associate Professor of Pathology and Pediatrics
Clinical Microbiology Laboratory
University of Michigan Medical School
Ann Arbor, MI, United States

Disclosure(s):

Esther Babady, PhD: Altona Diagnostics: Grant/Research Support (Ongoing); Bio-Rad: Advisor/Consultant (Ongoing); Copan Diagnostics: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); GenMark Dx/Roche: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing)

Thea Brennan-Krohn, MD, D(ABMM): PathAI: Board Member (Ongoing), Ownership Interest (Ongoing)

Nira R. Pollock, MD, PhD: No financial relationships to disclose

David C. Gaston, MD PhD: American Society of Microbiology: Honoraria (Terminated); DiaSorin: Honoraria (Terminated, September 10, 2023); Quidel: Honoraria (Terminated, October 6, 2023); T2Biosystems: Grant/Research Support (Ongoing)

Christopher R. Polage, MD, MAS: bioMeriuex/BioFire: Advisor/Consultant (Terminated); UpToDate Wolters Kluwer Health: Advisor/Consultant (Ongoing); Vast Therapeutics: Advisor/Consultant (Ongoing)

Stanley Deresinski, MD: No financial relationships to disclose

Monica V. Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP: ASHP: Honoraria (Ongoing); BD Diagnostics: Advisor/Consultant (Terminated, December 31, 2023); Cidara Therapeutics Inc.: Advisor/Consultant (Terminated, December 31, 2023); GSK: Advisor/Consultant (Ongoing); IDSA: Associate Editor (Ongoing); Merck Sharp & Dohme Corp: Grant/Research Support (Ongoing)

Virginia M. Pierce, MD: UpToDate, Inc.: Author royalties (Ongoing)

Learning Objectives:

At the conclusion of this session, participants will be able to:

Identify the limitations of diagnostic tests;
explain how to understand sensitivity and specificity of newer diagnostic tests;
use pretest probability to more appropriately order diagnostic tests;
master becoming advocates for "diagnostic stewardship".